Skip to main content
. 2019 Nov 4;3(11):e18.00090. doi: 10.5435/JAAOSGlobal-D-18-00090

Table 3.

Patients' Demographics for Each Disease

Factor OLF OPLL OPLL + OLF IET IMSCT VT SCH VF TDH
n 48 30 27 98 64 17 7 4 5
Sex
 Male 35 (72.9%) 17 (56.7%) 14 (51.9%) 51 (52.0%) 36 (56.3%) 9 (52.9%) 2 (28.6%) 1 (25.0%) 2 (40.0%)
 Female 13 (27.1%) 13 (43.3%) 13 (48.1%) 47 (48.0%) 28 (43.8%) 8 (47.1%) 5 (71.4%) 3 (75.0%) 3 (60.0%)
Mean age (years) 56.5 ± 15.6 yr 52.3 ± 14.8 yr 52.8 ± 10.4 yr 54.9 ± 16.4 yr 44.8 ± 16.4 yr 52.3 ± 18.5 yr 54.1 ± 9.4 yr 74.3 ± 6.4 yr 54.2 ± 12.6 yr
Mean disease duration (mo) 17.4 ± 18.8 mo 10.0 ± 9.6 mo 17.4 ± 26.5 mo 19.0 ± 40.7 mo 21.3 ± 40.0 mo 7.1 ± 14.1 mo 24.4 ± 42.3 mo 5.0 ± 3.6 mo 4.4 ± 3.5 mo
Preoperative JOA score 6.2 ± 2.5 4.8 ± 2.5 3.9 ± 2.4 6.4 ± 42.8 6.2 ± 2.6 4.1 ± 2.9 3.4 ± 1.5 5.3 ± 2.6 5.8 ± 3.9
Postoperative JOA score 8.2 ± 1.9 6.8 ± 2.0 6.2 ± 1.9 8.1 ± 2.1 7.3 ± 2.4 6.8 ± 1.8 5.9 ± 2.0 7.3 ± 2.9 7.0 ± 3.5
JOA recovery rate (%) 45.8 ± 21.6 35.5 ± 17.2 34.3 ± 18.7 42.1 ± 28.0 29.3 ± 33.0 36.5 ± 18.2 32.4 ± 18.5 47.2 ± 37.4 38.2 ± 35.3
Affected level
 Upper 7 (14.6%) 8 (26.7%) 5 (18.5%) 24 (24.5%) 16 (25.0%) 7 (41.2%) 2 (28.6%) 0 (0.0%) 0 (0.0%)
 Middle 3 (6.3%) 19 (63.3%) 18 (66.7%) 29 (29.6%) 16 (25.0%) 7 (41.2%) 5 (71.4%) 1 (25.0%) 3 (60.0%)
 Lower 38 (79.2%) 3 (10.0%) 3 (11.1%) 45 (45.9%) 32 (50.0%) 3 (17.6%) 0 (0.0%) 3 (75.0%) 2 (40.0%)
Initial/preoperative symptoms
 Girdle pain 0 (0%)/0 (0%) 2 (6.7%)/2 (6.7%) 1 (3.7%)/4 (4.1%) 4 (4.1%)/2 (7.4%) 7 (10.9%)/8 (12.5%) 5 (29.4%)/6 (35.3%) 0 (0.0%)/0 (0.0%) 0 (0.0%)/0 (0.0%) 0 (0.0%)/0 (0.0%)
 Back pain 0 (0%)/2 (4.2%) 3 (10.0%)/3 (10.2%) 3 (11.1%)/3 (11.1%) 17 (17.3%)/20 (20.4%) 16 (25.0%)/17 (26.6%) 7 (41.2%)/10 (58.8%) 0 (0.0%)/0 (0.0%) 2 (50.0%)/2 (50.0%) 0 (0.0%)/0 (0.0%)
 Low back pain 8 (16.7%)/12 (25.0%) 4 (13.3%)/6 (20.0%) 2 (7.4%)/3 (11.1%) 29 (29.6%)/34 (34.7%) 16 (25.0%)/19 (29.7%) 3 (17.6%)/3 (17.6%) 1 (14.3%)/2 (28.6%) 2 (50.0%)/2 (50.0%) 2 (40.0%)/2 (40.0%)
 Leg numbness 32 (66.7%)/33 (68.8%) 18 (60.0%)/23 (76.7%) 17 (63.0%)/21 (77.8%) 45 (45.9%)/63 (64.3%) 36 (56.3%)/50 (78.1%) 6 (35.3%)/10 (58.8%) 4 (57.1%)/4 (57.1%) 0 (0.0%)/3 (25.0%) 1 (20.0%)/2 (40.0%)
 Leg pain 8 (16.7%)/10 (20.8%) 4 (13.3%)/7 (23.3%) 2 (7.4%)/4 (14.8%) 22 (22.4%)/28 (28.6%) 10 (15.6%)/12 (18.8%) 2 (11.8%)/3 (17.6%) 1 (14.3%)/1 (14.3%) 0 (0.0%)/0 (0.0%) 1 (20.0%)/3 (60.0%)
 Gait disturbance 17 (35.4%)/31 (64.6%) 14 (46.7%)/27 (90.6%) 14 (51.9%)/23 (85.2)% 17 (17.3%)/48 (49.0)% 9 (14.1%)/35 (54.7)% 3 (17.6%)/15 (88.2)% 1 (14.3%)/7 (100%) 0 (0.0%)/3 (25.0%) 2 (40.0%)/3 (60.0)%
 Leg paresis 5 (10.4%)/10 (20.8%) 2 (6.7%)/13 (43.3%) 3 (11.1%)/11 (40.7%) 4 (4.1%)/28 (28.6%) 4 (6.3%)/17 (26.6%) 1 (5.9%)/12 (70.6%) 0 (0.0%)/3 (42.9%) 0 (0.0%)/3 (25.0%) 2 (40.0%)/3 (60.0)%
 BBD 1 (2.1%)/2 (4.2%) 2 (6.7%)/4 (13.3%) 0 (0.0%)/1 (3.7%) 1 (1.0%)/9 (9.2%) 3 (4.7%)/6 (9.4%) 2 (11.8%)/4 (23.5%) 0 (0.0%)/0 (0.0%) 0 (0.0%)/0 (0.0%) 0 (0.0%)/0 (0.0%)
Neurologic findings
 Hyper-PTR 29 (60.4%) 27 (90.0%) 24 (88.9%) 48 (49.0%) 41 (64.1%) 13 (76.5%) 6 (85.7%) 3 (75.0%) 4 (80.0%)
 Hyper-ATR 25 (52.1%) 22 (73.3%) 21 (77.8%) 43 (43.9%) 41 (64.1%) 15 (88.2%) 5 (71.4%) 2 (50.0%) 4 (80.0%)
 Positive ankle clonus 16 (33.3%) 20 (66.7%) 20 (74.1%) 28 (28.6%) 24 (37.5%) 9 (52.9%) 3 (42.9%) 0 (0.0%) 4 (80.0%)

ATR = ankle tendon reflex, BBD = bowel bladder disturbance, IET = intradural extramedullary tumor, IMSCT = intramedullary spinal cord tumor, JOA = Japanese Orthopaedic Association, OLF = ossification of the ligamentum flavum, OPLL = ossification of the posterior longitudinal ligament, PTR = patellar tendon reflex, SCH = spinal cord herniation, TDH = thoracic disk herniation, VF = vertebral fracture, VT = vertebral tumor